Approval · Notice of Compliance 11571 · 2010
GLUCOVISION: Notice of Compliance 11571
Issued July 2, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11571
- Date
- July 2, 2010
- Company
- Centre For Probe Development And CommercializationHamilton, Ontario, Canada
- Product type
- Radiopharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in name of manufacturer
- Therapeutic class
- Diagnostic radiopharmaceutical
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GLUCOVISION | Not yet assigned | — |
Medicinal ingredients
- FLUDEOXYGLUCOSE 18F 37 GBQ per VIAL